MCK McKesson Corporation
Updated
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
McKesson Corporation (MCK) is a industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $107.4 billion. Shares last traded at $921.18, 7.8% below their 52-week high. Over the past year the stock is up 33.3%. MCK trades at a price-to-earnings ratio of 23.39, below the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 23.95. Net profit margin is 1.1%, above the peer median of 0.7%. Revenue grew 12.4% year over year. The shares yield 0.3% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
MCK Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2026-03-31 | $381M | $3.07 | 8% |
| 2025-03-31 | $345M | $2.69 | 10% |
| 2024-03-31 | $314M | $2.34 | 10% |
| 2023-03-31 | $292M | $2.05 | 8% |
| 2022-03-31 | $277M | $1.80 | 25% |
| 2021-03-31 | $276M | $1.72 | — |
| 2020-03-31 | $294M | $1.62 | 33% |
| 2019-03-31 | $292M | $1.48 | 859% |
| 2018-03-31 | $262M | $1.25 | 391% |
| 2017-03-31 | $253M | $1.13 | 5% |
| 2016-03-31 | $244M | $1.05 | 11% |
| 2015-03-31 | $227M | $0.97 | 15% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2027 | $5.15 | 2026-08-05 |
| FY 2026 | $38.38 | 2026-05-08 |
| Q3 2026 | $24.73 | 2026-02-04 |
| Q2 2026 | $15.16 | 2025-11-06 |
| Q1 2027 | $6.25 | 2026-08-05 |
| FY 2026 | $25.72 | 2026-05-08 |
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
MCK vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Updated
| MCK | McKesson Corporation | $107.4B | 23.39 | 0.26 | 1.1% | -0.40% |
| COR | Cencora | $64.3B | 24.51 | 0.19 | 0.8% | +0.23% |
| CAH | Cardinal Health | $57.8B | 34.78 | 0.24 | 0.7% | +1.24% |
| HLF | Herbalife Ltd. | $1.3B | 7.76 | 0.25 | 3.2% | -0.08% |
| NUS | NU SKIN ENTERPRISES, INC. | $228M | -1.05 | 0.17 | -15.7% | -2.90% |
| COSM | Cosmos Health Inc. | $27M | -1.10 | 0.37 | -33.1% | +18.78% |
| HWH | HWH International Inc. | $15M | -5.54 | — | — | +2.98% |
| MEDS | DataMeds AI, Inc. | $3M | -0.03 | — | — | -4.49% |
| HKPD | Cellyan Biotechnology Co., Ltd | — | — | — | — | -7.89% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.